India says its pharma IP rules are WTO compliant as US pressure mounts over generics

India supplies one fifth of the world’s generics

India maintains that its intellectual property rules for pharmaceuticals are WTO compliant, even as the United States continues to press for stronger protections. The dispute comes as India supplies about 20% of global generic medicines, putting generics access and the domestic industry at the center of the argument. Both sides remain locked in long-running policy differences.